TRS 996 - Annex 1: WHO good pharmacopoeial practices

Overview

The main suggestion emerging from all these events was the development of  good pharmacopoeial practices (GPhP) to encourage harmonization, facilitated by WHO. It was agreed to develop the GPhP under the auspices of the WHO Expert Committee on Specifications for Pharmaceutical Preparations, benefiting from Annex 1 69 its well-established international standard-setting processes and procedures. These processes include an international consultation process, which enables the participation of all stakeholders and users in the development process. The final guidance would then be presented, in line with the procedure, to WHO’s 194 Member States and pharmacopoeial authorities.